ABT vs LUMN · P/E 25, rev $44.33B vs rev $5.70B
Abbott Laboratories (ABT) versus Lumen Technologies Inc (LUMN) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Lumen Technologies Inc (LUMN) is a telecom services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported LUMN revenue for 2026-06-30 was $5.70B. Net income was -$401.0M. Revenue was up 96.8% from 2026-03-31 to 2026-06-30. LUMN currently screens at market cap $4.72B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. LUMN currently screens at market cap $4.72B.
Not investment advice. Open the ABT and LUMN stock pages for the full models.
Not investment advice.